Future Perspectives of Catheter-Based Treatment in Valvular Heart Diseases

Chapter

Abstract

«The future from the past is not the present» (Hans R. Figulla)

Recent advances and successes in transcatheter valve technology (TVT) are not necessarily the most reliable and only predictor of the future of this exciting field; drawbacks and surprises are possible and could curb the current optimism in the future. It appears likely, however, that the field shall maintain its momentum with dwindling borderlines between cardiology and heart surgery and growing integration of tissue engineering, material sciences, and cellular biology in transcatheter valve technology (TVT) research and development. In this chapter we focus on the potentials and drawbacks of the present and emerging TVT technology and outline some of the future lines of research and applications.

References

  1. 1.
    Buchanan JW, Anderson JH, White RI. The 1st balloon valvuloplasty: an historical note. J Vet Intern Med. 2002;16(1):116–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87(3):394–402.PubMedGoogle Scholar
  3. 3.
    Lock JE, Khalilullah M, Shrivastava S, Bahl V, Keane JF. Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med. 1985;313(24):1515–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;1(8472):63–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13(5):704–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Pavcnik D, Wright KC, Wallace S. Development and initial experimental evaluation of a prosthetic aortic valve for transcatheter placement. Work in progress. Radiol. 1992;183(1):151–4.CrossRefGoogle Scholar
  7. 7.
    Ferrari M, Figulla HR, Schlosser M, Tenner I, Frerichs I, Damm C, Guyenot V, Werner GS, Hellige G. Transarterial aortic valve replacement with a self expanding stent in pigs. Heart. 2004;90(11):1326–31.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–8.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, Figulla HR. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 2011;32(10):1207–13.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67–84.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Joachim A, Daniels R, Francis V, Ogendo S, Gitura B, Mondo C, Okello E, Lwabi P, Al-Kebsi MM, Hugo-Hamman C, Sheta SS, Haileamlak A, Daniel W, Goshu DY, Abdissa SG, Desta AG, Shasho BA, Begna DM, Elsayed A, Ibrahim AS, Musuku J, Bode-Thomas F, Okeahialam BN, Ige O, Sutton C, Misra R, Abul Fadl A, Kennedy N, Damasceno A, Sani M, Ogah OS, Olunuga T, Elhassan HH, Mocumbi AO, Adeoye AM, Mntla P, Ojji D, Mucumbitsi J, Teo K, Yusuf S, Mayosi BM. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the global rheumatic heart disease registry (the REMEDY study). Eur Heart J. 2014;36(18):1115–22.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Iung B, Nicoud-Houel A, Fondard O, Hafid A, Haghighat T, Brochet E, Garbarz E, Cormier B, Baron G, Luxereau P, Vahanian A. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J. 2004;25(8):701–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Bouleti C, Iung B, Laouenan C, Himbert D, Brochet E, Messika-Zeitoun D, Detaint D, Garbarz E, Cormier B, Michel PL, Mentre F, Vahanian A. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation. 2012;125(17):2119–27.CrossRefPubMedGoogle Scholar
  15. 15.
    Iung B, Cormier B, Ducimetiere P, Porte JM, Nallet O, Michel PL, Acar J, Vahanian A. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation. 1996;94(9):2124–30.CrossRefPubMedGoogle Scholar
  16. 16.
    Hernandez R, Banuelos C, Alfonso F, Goicolea J, Fernandez-Ortiz A, Escaned J, Azcona L, Almeria C, Macaya C. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation. 1999;99(12):1580–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Ben Farhat M, Betbout F, Gamra H, Maatouk F, Ayari M, Cherif A, Jarrar M, Boussadia H, Hammami S, Chahbani I. Results of percutaneous double-balloon mitral commissurotomy in one medical center in Tunisia. Am J Cardiol. 1995;76(17):1266–70.CrossRefPubMedGoogle Scholar
  18. 18.
    Ben Farhat M, Betbout F, Gamra H, Maatouk F, Ayari M, Jarrar M, Cherif A, Chahbani I, Hammami S, Thaalbi R. Complications of percutaneous mitral commissurotomy. Personal experience and review of the literature. Arch Mal Coeur Vaiss. 1996;89(4):417–23.PubMedGoogle Scholar
  19. 19.
    Cribier A, Rath PC, Letac B. Percutaneous mitral valvotomy with a metal dilatator. Lancet. 1997;349(9066):1667.CrossRefPubMedGoogle Scholar
  20. 20.
    Good MF, Batzloff MR, Pandey M. Strategies in the development of vaccines to prevent infections with group a streptococcus. Hum Vaccin Immunother. 2013;9(11):2393–7.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron IL. Ctsn. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32.CrossRefPubMedGoogle Scholar
  22. 22.
    Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45(3):381–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Maisano F, Alfieri O, Banai S, Buchbinder M, Colombo A, Falk V, Feldman T, Franzen O, Herrmann H, Kar S, Kuck KH, Lutter G, Mack M, Nickenig G, Piazza N, Reisman M, Ruiz CE, Schofer J, Sondergaard L, Stone GW, Taramasso M, Thomas M, Vahanian A, Webb J, Windecker S, Leon MB. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. 2015;36(26):1651–9.CrossRefGoogle Scholar
  24. 24.
    De Backer O, Piazza N, Banai S, Lutter G, Maisano F, Herrmann HC, Franzen OW, Sondergaard L. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. 2014;7(3):400–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Mohr FW, Holzhey D, Mollmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Bohm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW, Board GE. The German aortic valve registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg official journal of the European Association for Cardio-thoracic Surgery. 2014;46(5):808–16.CrossRefGoogle Scholar
  26. 26.
    Kondur A, Briasoulis A, Palla M, Penumetcha A, Mallikethi-Reddy S, Badheka A, Schreiber T. Meta-analysis of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with severe aortic valve stenosis. Am J Cardiol. 2016;117(2):252–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, Investigators P. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefPubMedGoogle Scholar
  28. 28.
    Reardon MJ, Kleiman NS, Adams DH, Yakubov SJ, Coselli JS, Deeb GM, O’Hair D, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Huang J, Popma JJ. Outcomes in the randomized corevalve US pivotal high risk trial in patients with a society of thoracic surgeons risk score of 7% or less. JAMA Cardiol. 2016;1(8):945–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Seiffert M, Bader R, Kappert U, Rastan A, Krapf S, Bleiziffer S, Hofmann S, Arnold M, Kallenbach K, Conradi L, Schlingloff F, Wilbring M, Schafer U, Diemert P, Treede H. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv. 2014;7(10):1168–74.CrossRefPubMedGoogle Scholar
  30. 30.
    Rahmani B, Cousins B, Burriesci G, Seifalian AM. Encyclopedia of Biomedical Polymers and Polymeric Biomaterial. Heart Valves, Polymeric: Biocompatibility. CRC Press;2015.Google Scholar
  31. 31.
    Fish RD, Paniagua D, Urena P, Chevalier B. The Colibri heart valve: theory and practice in the achievement of a low-profile, pre-mounted, pre-packaged TAVI valve. EuroIntervention. 2013;9(Suppl):S111–4.CrossRefPubMedGoogle Scholar
  32. 32.
    Ribeiro PA, al Zaibag M, Idris MT. Percutaneous double balloon tricuspid valvotomy for severe tricuspid stenosis: 3-year follow-up study. Eur Heart J. 1990;11(12):1109–12.CrossRefPubMedGoogle Scholar
  33. 33.
    Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68.PubMedGoogle Scholar
  34. 34.
    Lauten A, Figulla HR. Tricuspid valve interventions in 2015. EuroIntervention. 2015;11(Suppl W):W133–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144(3):524–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Antunes MJ, Barlow JB. Management of tricuspid valve regurgitation. Heart. 2007;93(2):271–6.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Sagie A, Schwammenthal E, Newell JB, Harrell L, Joziatis TB, Weyman AE, Levine RA, Palacios IF. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1994;24(3):696–702.CrossRefPubMedGoogle Scholar
  39. 39.
    Filsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohn LH, Adams DH. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg. 2005;80(3):845–50.CrossRefPubMedGoogle Scholar
  40. 40.
    Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol. 2015;65(12):1190–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Rogers JH. Functional tricuspid regrugitation and new percutaneous concepts TCT. 2008. Available at www.tctmd.com.
  42. 42.
    Webb J, Thompson C, Perlman G, Leipsic J, Blanke P, Dvir D, Boone RH, Wood D, Ye J. Edwards FORMA repair system for tricuspid regurgitation. 2015. http://www.crtonlineorg/crt2015/premium/defaultaspx.
  43. 43.
    Van Garsse LA, Ter Bekke RM, van Ommen VG. Percutaneous transcatheter valve-in-valve implantation in stenosed tricuspid valve bioprosthesis. Circulation. 2011;123(5):e219–21.CrossRefPubMedGoogle Scholar
  44. 44.
    Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv. 2014;7(2):268–72.CrossRefPubMedGoogle Scholar
  45. 45.
    Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol. 2013;61(18):1929–31.CrossRefPubMedGoogle Scholar
  46. 46.
    Rao PS, Fawzy ME, Solymar L, Mardini MK. Long-term results of balloon pulmonary valvuloplasty of valvar pulmonic stenosis. Am Heart J. 1988;115(6):1291–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Harrild DM, Powell AJ, Tran TX, Geva T, Lock JE, Rhodes J, McElhinney DB. Long-term pulmonary regurgitation following balloon valvuloplasty for pulmonary stenosis risk factors and relationship to exercise capacity and ventricular volume and function. J Am Coll Cardiol. 2010;55(10):1041–7.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Radtke W, Keane JF, Fellows KE, Lang P, Lock JE. Percutaneous balloon valvotomy of congenital pulmonary stenosis using oversized balloons. J Am Coll Cardiol. 1986;8(4):909–15.CrossRefPubMedGoogle Scholar
  49. 49.
    Broberg CS, Jayaweera AR, Diller GP, Prasad SK, Thein SL, Bax BE, Burman J, Gatzoulis MA. Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease. Am J Cardiol. 2011;107(4):595–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Frigiola A, Tsang V, Bull C, Coats L, Khambadkone S, Derrick G, Mist B, Walker F, van Doorn C, Bonhoeffer P, Taylor AM. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation. 2008;118(14 Suppl):S182–90.CrossRefPubMedGoogle Scholar
  51. 51.
    Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T, Busch R, Hess J, Berger F. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32(10):1260–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, Shirali G, Fogel M, Fahey J, Heitschmidt MG, Cain C. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58(21):2248–56.CrossRefPubMedGoogle Scholar
  53. 53.
    Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, Malhotra R, O’Brien KD, Kamstrup PR, Nordestgaard BG, Tybjaerg-Hansen A, Allison MA, Aspelund T, Criqui MH, Heckbert SR, Hwang SJ, Liu Y, Sjogren M, van der Pals J, Kalsch H, Muhleisen TW, Nothen MM, Cupples LA, Caslake M, Di Angelantonio E, Danesh J, Rotter JI, Sigurdsson S, Wong Q, Erbel R, Kathiresan S, Melander O, Gudnason V, O’Donnell CJ, Post WS, Group CECW. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368(6):503–12.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Friedrich Schiller UniversitätJenaGermany
  2. 2.Charité- Universitaetsmedizin Berlin, Department of Cardiology BerlinBerlinGermany

Personalised recommendations